MangoRx vs YourHealthRx

Both answer the needle question. Only one answers the rest.

For a reader whose real objection to GLP-1 treatment is the injection, this is the pairing that matters. MangoRx sells a compounded oral semaglutide tablet. YourHealthRx offers a daily dissolving tablet as well, and a weekly injection if you change your mind.

Past that, the two records are not comparable in depth. YourHealthRx publishes a fifty-state-plus-DC licensure footprint, both compounds, and a program that folds lab work and follow-up in. MangoRx publishes a price and a tablet.

A daily tablet is also a different habit than a weekly shot. Easier to begin, easier to forget. Be honest about which failure mode you are more prone to before treating the format as the whole decision.

The twenty-five day cycle is the most expensive detail here

MangoRx's subscribe-and-save cycle refills every twenty-five days rather than every calendar month. A twenty-five day cycle produces more fills in a year than twelve.

A reader who files the published figure as a monthly cost and multiplies by twelve will underestimate the annual total, in the provider's favor, every time. The figure is not wrong. The assumption brought to it is.

YourHealthRx bills monthly, but carries its own trap: the rate it advertises is a discounted introductory month, and the ongoing rate from month two is higher. Normalize both providers to the same period and to the rate you will actually be paying before comparing anything.

Where each one can serve you

YourHealthRx works with a clinician network licensed across all fifty states and DC through the Interstate Medical Licensure Compact. A reader in a smaller market can proceed without checking a coverage map.

MangoRx publishes no list of states served. No published list is not the same thing as nationwide availability, and that gap stays a gap. A reader outside a major market should establish availability with MangoRx directly before starting an intake.

That single difference rules MangoRx out for a large group of readers before price enters the conversation.

Who you are dealing with

MangoRx operates under Mangoceuticals, listed on the Nasdaq as MGRX. A publicly traded parent carries SEC reporting obligations most privately held telehealth brands do not, so a determined reader can pull filings rather than guess at the business. In a category full of entities a customer cannot identify, that is checkable and real.

It is also narrow. Public reporting says nothing about which pharmacy compounds the tablet, what accreditation that pharmacy holds, or whether the service is licensed where you live. Corporate transparency and clinical transparency are separate things.

YourHealthRx describes itself as the technology and commerce layer, with eligibility and prescribing handled inside partner clinical operations. That is common in telehealth rather than a defect, but it changes who to contact when something goes wrong. Ask at intake who reviews eligibility, who signs the prescription, who answers a side-effect question, and who handles a shipment.

What neither publishes

Neither names the pharmacy that compounds and dispenses the medication. MangoRx discloses no third-party pharmacy accreditation beyond a general claim of licensure. YourHealthRx displays no LegitScript seal.

Both sell compounded products only. Compounded semaglutide and tirzepatide are prepared by a compounding pharmacy and are not FDA-approved finished drug products. Neither publishes a brand-name option.

So which one

It depends on which of these matters more to you. If you are already using MangoRx for testosterone or hair loss and want one login and one clinical relationship, that consolidation is real, and the oral tablet is the product it is built around.

If you need to confirm your state is served, want tirzepatide as well as semaglutide, or want the option to switch formats later, YourHealthRx publishes all three. MangoRx publishes none of them.